EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Maximal use of 0.05% topical isotretinoin in patients with congenital ichthyosis results in low systemic exposure

Holm Schneider iD, Christopher G Bunick, Kathrin Hillmann, Thy N Huynh, Steven Kempers, Nicolai Peschel, Ulrike Blume-Peytavi, Joyce M C Teng, Alan M Mendelsohn, John Stinson, Lara Wine Lee

British Journal of Clinical Pharmacology · 2025

DOI: 10.1002/bcp.70423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Holm Schneider und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany. Hauptthemen laut MEDLINE: Isotretinoin, Dermatologic Agents. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Timber Pharmaceuticals, LEO Pharma A/S.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital ichthyoses (CI) are rare, inherited skin disorders characterized by hyperkeratosis, scaling and fissuring that significantly impair patients' quality of life. Treatment options are limited, with systemic retinoids reserved for severe cases owing to their adverse effect profile. This open‐label, single‐arm, maximal‐use trial investigated the systemic exposure and safety of a topically administered isotretinoin ointment (TMB‐001 0.05%) in patients with moderate‐to‐severe CI. Thirty‐four patients aged ≥6 years applied TMB‐001 0.05% under maximal‐use conditions (twice daily to 75%–90% of the body surface area) for 14 days, with continued application for another 10 weeks. Exposure levels for TMB‐001 0.05% and its metabolites were < 1% of those observed after single oral administration of 80 mg isotretinoin to healthy adults. A majority of patients had local safety or tolerability issues, most of which were mild. Overall, the treatment was well tolerated with no evidence of systemic toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsotretinoinDermatologic AgentsHumansMaleFemaleAdultChildAdolescentYoung AdultMiddle AgedAdministration, TopicalOintmentsAdministration, CutaneousAgedTreatment Outcome

Stichwörter der Autor:innen

ARCIRXLITMB‐001pharmacokineticsretinoids

Substanzen

IsotretinoinDermatologic AgentsOintments

Autor:innen und Institutionen

  • Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany.
  • Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Dermatology, Venereology and Allergology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Dermatology, University of Mississippi, Jackson, Mississippi, USA.
  • Associated Skin Care Specialists, New Brighton, Minnesota, USA.
  • Department of Dermatology, Stanford University School of Medicine, Palo Alto, California, USA.

ORCID-Profile: Holm Schneider

Förderung

  • Timber Pharmaceuticals
  • LEO Pharma A/S

Zitieren

APA

Schneider, H., Bunick, C. G., Hillmann, K., Huynh, T. N., Kempers, S., Peschel, N., Blume-Peytavi, U., Teng, J. M. C., Mendelsohn, A. M., Stinson, J., & Lee, L. W. (2025). Maximal use of 0.05% topical isotretinoin in patients with congenital ichthyosis results in low systemic exposure. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70423

Vancouver

Schneider H, Bunick CG, Hillmann K, Huynh TN, Kempers S, Peschel N, et al. Maximal use of 0.05% topical isotretinoin in patients with congenital ichthyosis results in low systemic exposure. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70423

BibTeX
@article{Schneider2025,
  author = {Schneider, Holm and Bunick, Christopher G and Hillmann, Kathrin and Huynh, Thy N and Kempers, Steven and Peschel, Nicolai and Blume-Peytavi, Ulrike and Teng, Joyce M C and Mendelsohn, Alan M and Stinson, John and Lee, Lara Wine},
  title = {Maximal use of 0.05% topical isotretinoin in patients with congenital ichthyosis results in low systemic exposure},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/bcp.70423}
}
Kostenlos starten →